Increasing Prevalence of Disease: Rising incidence of prostate cancer globally is a key driver contributing to growth of castrate resistant prostate cancer market.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |